APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lung AI-assisted Diagnosis Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Lung AI-assisted Diagnosis Software Market Outlook and Growth Opportunities 2026

6 March 2026192 pages

Choose your research edition.

Industry ResearchLung AI-assisted Diagnosis Software Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Lung AI-assisted Diagnosis Software Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Lung AI-assisted Diagnosis Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lung AI-assisted Diagnosis Software Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Lung AI-assisted Diagnosis Software Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Lung AI-assisted Diagnosis Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Lung AI-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lung AI-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lung AI-assisted Diagnosis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Lung AI-assisted Diagnosis Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Lung AI-assisted Diagnosis Software market include Sense Time, United Imaging, Huiying Medical, Yizhun, BioMind, Shukun, Infervision, Deepwise and Optellum, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Lung AI-assisted Diagnosis Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lung AI-assisted Diagnosis Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lung AI-assisted Diagnosis Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Lung AI-assisted Diagnosis Software market.

Lung AI-assisted Diagnosis Software Segment by Company

Sense Time

United Imaging

Huiying Medical

Yizhun

BioMind

Shukun

Infervision

Deepwise

Optellum

IMLINCS

NeuMiva

Yitu

FOSUN AITROX

VoxelCloud

Lung AI-assisted Diagnosis Software Segment by Type

Public Cloud

Private Cloud

Lung AI-assisted Diagnosis Software Segment by Application

Hospital

Clinic

Imaging Center

Lung AI-assisted Diagnosis Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Lung AI-assisted Diagnosis Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Lung AI-assisted Diagnosis Software key companies, revenue, market share, and recent developments.

3. To split the Lung AI-assisted Diagnosis Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Lung AI-assisted Diagnosis Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Lung AI-assisted Diagnosis Software significant trends, drivers, influence factors in global and regions.

6. To analyze Lung AI-assisted Diagnosis Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lung AI-assisted Diagnosis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lung AI-assisted Diagnosis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lung AI-assisted Diagnosis Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Lung AI-assisted Diagnosis Software industry.

Chapter 3: Detailed analysis of Lung AI-assisted Diagnosis Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Lung AI-assisted Diagnosis Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Lung AI-assisted Diagnosis Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Lung AI-assisted Diagnosis Software Industry Trends Table 2. Lung AI-assisted Diagnosis Software Industry Drivers Table 3. Lung AI-assisted Diagnosis Software Industry Opportunities and Challenges Table 4. Lung AI-assisted Diagnosis Software Industry Restraints Table 5. Global Lung AI-assisted Diagnosis Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Lung AI-assisted Diagnosis Software Revenue Share by Company (2021-2026) Table 7. Global Lung AI-assisted Diagnosis Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Lung AI-assisted Diagnosis Software Key Company Manufacturing Base & Headquarters Table 9. Global Lung AI-assisted Diagnosis Software Company, Product Type & Application Table 10. Global Lung AI-assisted Diagnosis Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Lung AI-assisted Diagnosis Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Public Cloud Table 15. Significant Companies of Private Cloud Table 16. Global Lung AI-assisted Diagnosis Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Lung AI-assisted Diagnosis Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Lung AI-assisted Diagnosis Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Lung AI-assisted Diagnosis Software Sales Value Share by Type (2021-2026) Table 20. Global Lung AI-assisted Diagnosis Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Clinic Table 23. Significant Companies of Imaging Center Table 24. Global Lung AI-assisted Diagnosis Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Lung AI-assisted Diagnosis Software Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Lung AI-assisted Diagnosis Software Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Lung AI-assisted Diagnosis Software Sales Value Share by Application (2021-2026) Table 28. Global Lung AI-assisted Diagnosis Software Sales Value Share by Application (2027-2032) Table 29. Global Lung AI-assisted Diagnosis Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Lung AI-assisted Diagnosis Software Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Lung AI-assisted Diagnosis Software Sales Value Share by Region (2021-2026) Table 32. Global Lung AI-assisted Diagnosis Software Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Lung AI-assisted Diagnosis Software Sales Value Share by Region (2027-2032) Table 34. Global Lung AI-assisted Diagnosis Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Lung AI-assisted Diagnosis Software Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Lung AI-assisted Diagnosis Software Sales Value Market Share by Country (2021-2026) Table 37. Global Lung AI-assisted Diagnosis Software Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Lung AI-assisted Diagnosis Software Sales Value Market Share by Country (2027-2032) Table 39. Sense Time Company Information Table 40. Sense Time Business Overview Table 41. Sense Time Lung AI-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Sense Time Lung AI-assisted Diagnosis Software Product Portfolio Table 43. Sense Time Recent Development Table 44. United Imaging Company Information Table 45. United Imaging Business Overview Table 46. United Imaging Lung AI-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. United Imaging Lung AI-assisted Diagnosis Software Product Portfolio Table 48. United Imaging Recent Development Table 49. Huiying Medical Company Information Table 50. Huiying Medical Business Overview Table 51. Huiying Medical Lung AI-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Huiying Medical Lung AI-assisted Diagnosis Software Product Portfolio Table 53. Huiying Medical Recent Development Table 54. Yizhun Company Information Table 55. Yizhun Business Overview Table 56. Yizhun Lung AI-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Yizhun Lung AI-assisted Diagnosis Software Product Portfolio Table 58. Yizhun Recent Development Table 59. BioMind Company Information Table 60. BioMind Business Overview Table 61. BioMind Lung AI-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. BioMind Lung AI-assisted Diagnosis Software Product Portfolio Table 63. BioMind Recent Development Table 64. Shukun Company Information Table 65. Shukun Business Overview Table 66. Shukun Lung AI-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Shukun Lung AI-assisted Diagnosis Software Product Portfolio Table 68. Shukun Recent Development Table 69. Infervision Company Information Table 70. Infervision Business Overview Table 71. Infervision Lung AI-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Infervision Lung AI-assisted Diagnosis Software Product Portfolio Table 73. Infervision Recent Development Table 74. Deepwise Company Information Table 75. Deepwise Business Overview Table 76. Deepwise Lung AI-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Deepwise Lung AI-assisted Diagnosis Software Product Portfolio Table 78. Deepwise Recent Development Table 79. Optellum Company Information Table 80. Optellum Business Overview Table 81. Optellum Lung AI-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Optellum Lung AI-assisted Diagnosis Software Product Portfolio Table 83. Optellum Recent Development Table 84. IMLINCS Company Information Table 85. IMLINCS Business Overview Table 86. IMLINCS Lung AI-assisted Diagnosis Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. IMLINCS Lung AI-assisted Diagnosis Software Product Portfolio Table 88. IMLINCS Recent Development Table 89. NeuMiva Company Information Table 90. NeuMiva Business Overview Table 91. NeuMiva Lung AI-assisted Diagnosis Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. NeuMiva Lung AI-assisted Diagnosis Software Product Portfolio Table 93. NeuMiva Recent Development Table 94. Yitu Company Information Table 95. Yitu Business Overview Table 96. Yitu Lung AI-assisted Diagnosis Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Yitu Lung AI-assisted Diagnosis Software Product Portfolio Table 98. Yitu Recent Development Table 99. FOSUN AITROX Company Information Table 100. FOSUN AITROX Business Overview Table 101. FOSUN AITROX Lung AI-assisted Diagnosis Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. FOSUN AITROX Lung AI-assisted Diagnosis Software Product Portfolio Table 103. FOSUN AITROX Recent Development Table 104. VoxelCloud Company Information Table 105. VoxelCloud Business Overview Table 106. VoxelCloud Lung AI-assisted Diagnosis Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. VoxelCloud Lung AI-assisted Diagnosis Software Product Portfolio Table 108. VoxelCloud Recent Development Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Lung AI-assisted Diagnosis Software Product Image Figure 2. Global Lung AI-assisted Diagnosis Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lung AI-assisted Diagnosis Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Lung AI-assisted Diagnosis Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Public Cloud Image Figure 8. Private Cloud Image Figure 9. Global Lung AI-assisted Diagnosis Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Lung AI-assisted Diagnosis Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Lung AI-assisted Diagnosis Software Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Imaging Center Image Figure 15. Global Lung AI-assisted Diagnosis Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Lung AI-assisted Diagnosis Software Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Lung AI-assisted Diagnosis Software Sales Value Share by Application (2021-2032) Figure 18. Global Lung AI-assisted Diagnosis Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Lung AI-assisted Diagnosis Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Lung AI-assisted Diagnosis Software Sales Value (2021-2032) & (US$ Million) Figure 21. North America Lung AI-assisted Diagnosis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Lung AI-assisted Diagnosis Software Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Lung AI-assisted Diagnosis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Lung AI-assisted Diagnosis Software Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Lung AI-assisted Diagnosis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Lung AI-assisted Diagnosis Software Sales Value (2021-2032) & (US$ Million) Figure 27. South America Lung AI-assisted Diagnosis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Lung AI-assisted Diagnosis Software Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Lung AI-assisted Diagnosis Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Public Cloud
  • Private Cloud
Applications
  • Hospital
  • Clinic
  • Imaging Center
Companies covered
  • Sense Time
  • United Imaging
  • Huiying Medical
  • Yizhun
  • BioMind
  • Shukun
  • Infervision
  • Deepwise
  • Optellum
  • IMLINCS
  • NeuMiva
  • Yitu
  • FOSUN AITROX
  • VoxelCloud

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Lung AI-assisted Diagnosis Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Lung AI-assisted Diagnosis Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Lung AI-assisted Diagnosis Software Market Dynamics
  1. 2.1 Lung AI-assisted Diagnosis Software Industry Trends
  2. 2.2 Lung AI-assisted Diagnosis Software Industry Drivers
  3. 2.3 Lung AI-assisted Diagnosis Software Industry Opportunities and Challenges
  4. 2.4 Lung AI-assisted Diagnosis Software Industry Restraints
3 Lung AI-assisted Diagnosis Software Market by Company
  1. 3.1 Global Lung AI-assisted Diagnosis Software Company Revenue Ranking in 2025
  2. 3.2 Global Lung AI-assisted Diagnosis Software Revenue by Company (2021-2026)
  3. 3.3 Global Lung AI-assisted Diagnosis Software Company Ranking (2024-2026)
  4. 3.4 Global Lung AI-assisted Diagnosis Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Lung AI-assisted Diagnosis Software Company Product Type and Application
  6. 3.6 Global Lung AI-assisted Diagnosis Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Lung AI-assisted Diagnosis Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Lung AI-assisted Diagnosis Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Lung AI-assisted Diagnosis Software Market by Type
  1. 4.1 Lung AI-assisted Diagnosis Software Type Introduction
  2. 4.1.1 Public Cloud
  3. 4.1.2 Private Cloud
  4. 4.2 Global Lung AI-assisted Diagnosis Software Sales Value by Type
  5. 4.2.1 Global Lung AI-assisted Diagnosis Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Lung AI-assisted Diagnosis Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global Lung AI-assisted Diagnosis Software Sales Value Share by Type (2021-2032)
5 Lung AI-assisted Diagnosis Software Market by Application
  1. 5.1 Lung AI-assisted Diagnosis Software Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Imaging Center
  5. 5.2 Global Lung AI-assisted Diagnosis Software Sales Value by Application
  6. 5.2.1 Global Lung AI-assisted Diagnosis Software Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lung AI-assisted Diagnosis Software Sales Value by Application (2021-2032)
  8. 5.2.3 Global Lung AI-assisted Diagnosis Software Sales Value Share by Application (2021-2032)
6 Lung AI-assisted Diagnosis Software Regional Value Analysis
  1. 6.1 Global Lung AI-assisted Diagnosis Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lung AI-assisted Diagnosis Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Lung AI-assisted Diagnosis Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Lung AI-assisted Diagnosis Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Lung AI-assisted Diagnosis Software Sales Value (2021-2032)
  7. 6.3.2 North America Lung AI-assisted Diagnosis Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Lung AI-assisted Diagnosis Software Sales Value (2021-2032)
  10. 6.4.2 Europe Lung AI-assisted Diagnosis Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Lung AI-assisted Diagnosis Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Lung AI-assisted Diagnosis Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Lung AI-assisted Diagnosis Software Sales Value (2021-2032)
  16. 6.6.2 South America Lung AI-assisted Diagnosis Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Lung AI-assisted Diagnosis Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Lung AI-assisted Diagnosis Software Sales Value Share by Country, 2025 VS 2032
7 Lung AI-assisted Diagnosis Software Country-level Value Analysis
  1. 7.1 Global Lung AI-assisted Diagnosis Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Lung AI-assisted Diagnosis Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Lung AI-assisted Diagnosis Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Lung AI-assisted Diagnosis Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Lung AI-assisted Diagnosis Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Lung AI-assisted Diagnosis Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Lung AI-assisted Diagnosis Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sense Time
  2. 8.1.1 Sense Time Company Information
  3. 8.1.2 Sense Time Business Overview
  4. 8.1.3 Sense Time Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sense Time Lung AI-assisted Diagnosis Software Product Portfolio
  6. 8.1.5 Sense Time Recent Developments
  7. 8.2 United Imaging
  8. 8.2.1 United Imaging Company Information
  9. 8.2.2 United Imaging Business Overview
  10. 8.2.3 United Imaging Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 United Imaging Lung AI-assisted Diagnosis Software Product Portfolio
  12. 8.2.5 United Imaging Recent Developments
  13. 8.3 Huiying Medical
  14. 8.3.1 Huiying Medical Company Information
  15. 8.3.2 Huiying Medical Business Overview
  16. 8.3.3 Huiying Medical Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Huiying Medical Lung AI-assisted Diagnosis Software Product Portfolio
  18. 8.3.5 Huiying Medical Recent Developments
  19. 8.4 Yizhun
  20. 8.4.1 Yizhun Company Information
  21. 8.4.2 Yizhun Business Overview
  22. 8.4.3 Yizhun Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Yizhun Lung AI-assisted Diagnosis Software Product Portfolio
  24. 8.4.5 Yizhun Recent Developments
  25. 8.5 BioMind
  26. 8.5.1 BioMind Company Information
  27. 8.5.2 BioMind Business Overview
  28. 8.5.3 BioMind Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 BioMind Lung AI-assisted Diagnosis Software Product Portfolio
  30. 8.5.5 BioMind Recent Developments
  31. 8.6 Shukun
  32. 8.6.1 Shukun Company Information
  33. 8.6.2 Shukun Business Overview
  34. 8.6.3 Shukun Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shukun Lung AI-assisted Diagnosis Software Product Portfolio
  36. 8.6.5 Shukun Recent Developments
  37. 8.7 Infervision
  38. 8.7.1 Infervision Company Information
  39. 8.7.2 Infervision Business Overview
  40. 8.7.3 Infervision Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Infervision Lung AI-assisted Diagnosis Software Product Portfolio
  42. 8.7.5 Infervision Recent Developments
  43. 8.8 Deepwise
  44. 8.8.1 Deepwise Company Information
  45. 8.8.2 Deepwise Business Overview
  46. 8.8.3 Deepwise Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Deepwise Lung AI-assisted Diagnosis Software Product Portfolio
  48. 8.8.5 Deepwise Recent Developments
  49. 8.9 Optellum
  50. 8.9.1 Optellum Company Information
  51. 8.9.2 Optellum Business Overview
  52. 8.9.3 Optellum Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Optellum Lung AI-assisted Diagnosis Software Product Portfolio
  54. 8.9.5 Optellum Recent Developments
  55. 8.10 IMLINCS
  56. 8.10.1 IMLINCS Company Information
  57. 8.10.2 IMLINCS Business Overview
  58. 8.10.3 IMLINCS Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 IMLINCS Lung AI-assisted Diagnosis Software Product Portfolio
  60. 8.10.5 IMLINCS Recent Developments
  61. 8.11 NeuMiva
  62. 8.11.1 NeuMiva Company Information
  63. 8.11.2 NeuMiva Business Overview
  64. 8.11.3 NeuMiva Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 NeuMiva Lung AI-assisted Diagnosis Software Product Portfolio
  66. 8.11.5 NeuMiva Recent Developments
  67. 8.12 Yitu
  68. 8.12.1 Yitu Company Information
  69. 8.12.2 Yitu Business Overview
  70. 8.12.3 Yitu Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Yitu Lung AI-assisted Diagnosis Software Product Portfolio
  72. 8.12.5 Yitu Recent Developments
  73. 8.13 FOSUN AITROX
  74. 8.13.1 FOSUN AITROX Company Information
  75. 8.13.2 FOSUN AITROX Business Overview
  76. 8.13.3 FOSUN AITROX Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 FOSUN AITROX Lung AI-assisted Diagnosis Software Product Portfolio
  78. 8.13.5 FOSUN AITROX Recent Developments
  79. 8.14 VoxelCloud
  80. 8.14.1 VoxelCloud Company Information
  81. 8.14.2 VoxelCloud Business Overview
  82. 8.14.3 VoxelCloud Lung AI-assisted Diagnosis Software Revenue and Gross Margin (2021-2026)
  83. 8.14.4 VoxelCloud Lung AI-assisted Diagnosis Software Product Portfolio
  84. 8.14.5 VoxelCloud Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst